PRA Health Sciences (PRAH) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook

Go back to PRA Health Sciences (PRAH) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook

PRA Health Sciences, Inc. Reports First Quarter 2016 Results and Updates 2016 Guidance

April 27, 2016 4:00 PM EDT

$372.3 million of service revenue in the first quarter; 13.0% constant currency growth compared to the first quarter of 2015 First quarter GAAP Net Loss of $16.0 million or $0.27 per diluted share, which includes $28.9 million of one-time transaction-related costs and a $21.5 million loss from the completion of our Senior Note tender offer $67.4 million of Adjusted EBITDA in the first quarter; 20.8% growth compared to the first quarter of 2015 First quarter Adjusted Net Income per diluted share increased 34.1% to $0.55 per share and Adjusted Net Income increased 35.2% to $34.9 million compared to the... More